V030-5197 Screening compound: 1-[6-(3,5-dimethoxybenzoyl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]-4-methylpiperazine

V030-5197 Screening compound: 1-[6-(3,5-dimethoxybenzoyl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]-4-methylpiperazine
V030-5197 Screening compound: 1-[6-(3,5-dimethoxybenzoyl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]-4-methylpiperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-5197
1-[6-(3,5-dimethoxybenzoyl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]-4-methylpiperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-5197

Molecular Formula

C25H34N6O3 (C25 H34 N6 O3)

Compound Name

1-[6-(3,5-dimethoxybenzoyl)-2-(pyrrolidin-1-yl)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-4-yl]-4-methylpiperazine

IUPAC name

1-[6-(35-dimethoxybenzoyl)-2-(pyrrolidin-1-yl)-5H6H7H8H-pyrido[43-d]pyrimidin-4-yl]-4-methylpiperazine

SMILES

CN(CC1)CCN1c1c(CN(CC2)C(c3cc(OC)cc(OC)c3)=O)c2nc(N2CCCC2)n1

InChI

InChI=1S/C25H34N6O3/c1-28-10-12-29(13-11-28)23-21-17-31(24(32)18-14-19(33-2)16-20(15-18)34-3)9-6-22(21)26-25(27-23)30-7-4-5-8-30/h14-16H,4-13,17H2,1-3H3

InChI Key

LEYPFMKBWOYMPX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19933014

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

466.58

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.080

Distribution Coefficient, logD

1.899

Water Solubility, LogSw

-3.20

Polar Surface Area

61.316

Acid Dissociation Constant (pKa)

19.71

Base Dissociation Constant (pKb)

8.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

56.00

V030-5197 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with V030-5197 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-5197?
Check Price and Availability of V030-5197, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-5197 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-5197
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-5197
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-5197 available by request